Landiolol to prevent fast heart rate during major surgery
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a short-acting medicine called landiolol to see if it can prevent dangerously fast heart rates during and after major surgery. It is for people who have heart risks and are having a planned non-cardiac surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older.
- Your surgery is scheduled ahead of time (not an emergency) and is considered moderate or high risk for your heart.
- You will be under general anesthesia and stay in the hospital for at least 24 hours.
- You have at least two of these conditions: age 75+, high blood pressure, heart disease, past heart failure, stroke, diabetes, poor kidney function, or high NT-proBNP levels.
- An exercise test showed that your heart rate responds abnormally (too fast or too slow to recover).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether landiolol (a short-acting heart-rate–lowering medicine) can reduce deaths compared with standard care in people in septic shock who have a fast heart rate and strong heart pumping. It is meant for a very specific type of critically ill patient while they are on a breathing machine.
This trial tests how well an “induction agent” medication works during major surgery to help keep blood pressure stable. It may help prevent complications in people at higher risk, especially those staying overnight in the hospital.
This trial compares a simple leg-raising technique to a medicine (noradrenaline) to help keep blood pressure stable during heart bypass surgery. It may help you avoid stronger drugs and have a smoother recovery.
This trial tests a short-acting beta-blocker called Landiolol given during mitral valve surgery to see if it helps the heart recover after surgery. It is for patients who have certain signs of heart strain before their operation.
This Phase 3 trial tests whether landiolol (a short-acting heart-rate–lowering medicine) can improve blood circulation in adults with septic shock whose heart rate is too fast. Doctors will also check that the medication is safe in this critical-care setting.
This trial tests whether a low dose of esmolol (a short-acting heart-rate medicine) can reduce heart muscle injury after non-heart surgery in older, frail people. It may help lower the chance of heart-related complications around the time of surgery.
Hear when a new Perioperative Myocardial Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.